Konstantinos Alataris
unknown0.0Global Dominance: 0.00%
Konstantinos Alataris is set to join the board of Oryzon Genomics, contributing his expertise in biotechnology and strategic development to support the company's growth and advancements in psychiatric treatment.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Konstantinos Alataris is proposed to be a new member of the Oryzon board.
Oryzon duplica su valor en Bolsa desde enero con sus últimos avances en tratamientos en psiquiatría | EmpresasEl País·
Spain· 2025-02-24
Spain· 2025-02-24
